Tetracosactide

替可克肽

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTetracosactide
Drug Alias Name替可沙肽Cosyntropin促皮质24肽二十四肽促皮质素Cortrosyn +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMelanocortin receptor agonists
TargetsMelanocortin receptor
Therapy Area/IndicationsDiagnostic agentsAdrenal InsufficiencyLecithin Cholesterol Acyltransferase Deficiency +[6] 
Global Approved IndicationsDiagnostic agentsAdrenal Insufficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1970/04/22
Country/TerritoryBulgariaUnited StatesSerbia +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmphastar
China Registration ClassN/A

Develop Information

Active CompaniesAmphastar Pharmaceuticals Inc
Inactive CompaniesMallinckrodt Ard LlcUniversity Of Virginia
Active IndicationsDiagnostic agentsAdrenal Insufficiency
Inactive IndicationsLecithin Cholesterol Acyltransferase DeficiencyAnemiaLiver Cirrhosis +[4] 

Other Information

ATC CodeH01AA02
Related LinksWikipediaDrugBankKEGG